Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02189122 · ClinicalTrials.gov registry record · NA
Comparative Effects of Aspirin and NHP-544C
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT02189122: Completed NA study, sponsored by Vanderbilt University.
NCT02189122 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02189122, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The investigators will compare the effects of rapid release aspirin and NHP-544C on the prostacyclin response to intravenous bradykinin.
Interventions
- DRUG Aspirin 162 mg
- DRUG Aspirin 81 mg
- DRUG Bradykinin
- DRUG NHP544-C 81 mg
- DRUG NHP544C 162 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-07 |
| Phase | NA |
What the finished NCT02189122 record still lists
NCT02189122 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 5 interventions - of which Aspirin 162 mg is the first listed.
NCT02189122 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02189122 about?
NCT02189122 is a clinical study titled "Comparative Effects of Aspirin and NHP-544C". The investigators will compare the effects of rapid release aspirin and NHP-544C on the prostacyclin response to intravenous bradykinin.
What is the current status of trial NCT02189122?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2014-07. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02189122?
The interventions under investigation include: Aspirin 162 mg (DRUG), Aspirin 81 mg (DRUG), Bradykinin (DRUG), NHP544-C 81 mg (DRUG), NHP544C 162 mg (DRUG).
Who is sponsoring clinical trial NCT02189122?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02189122's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia